Irbcc

Information

Price

Enrollment Start Date

20th August, 2023

Enrollment End Date

20th July, 2025

Language

English

Course Start Date

20th August, 2023

Course End Date

20th August 2025

About this Course

The International Retinoblastoma Comprehensive Course (IRBCC) was designed to serve as a foundational element for eye cancer specialists. It was prepared by more than 50 internationally renowned experts to provide detailed practical guidance and advice on the diagnosis and management of retinoblastoma (RB). Course graduates will acquire state-of-the-art knowledge on the genetics, pathogenesis, diagnosis and treatment of this life-threatening childhood cancer. This course was devised to reduce the world-wide mortality and vision loss associated with this cancer in both developing and developed countries. IRBCC offers the latest knowledge in a format that allows for rapid retrieval of information in daily practice. Graduates of this course will be able to classify, diagnose, and consider most suitable treatment options for differently staged retinoblastomas. By reading and watching IRBCC videos, graduates will have been introduced to retinoblastoma specialists around the world.

Meet the Faculty

Dr. Paul T. Finger

(Chairman Eye Cancer Foundation) MD, FACS

Dr. Paul T. Finger, MD, FACS, is an ophthalmologist, who has specialized in ocular oncology (ocular tumor, orbital disease and ophthalmic radiation therapy). A Clinical Professor of Ophthalmology at the New York University School of Medicine, he is also the director of The New York Eye Cancer Center and Ocular Tumor Services at The New York Eye and Ear Infirmary of Mt. Sinai. He consults for Northwell Health Complex of affiliated Hospitals including Manhattan Eye, Ear and Throat Hospital. Founding The Eye Cancer Foundation, Dr. Finger has directed this charity to support international multicenter cooperation and outreach to underserved and underserved countries.

As a foundational element to his international work, he has served two terms as Chair of the American Joint Committee on Cancer (AJCC) Ophthalmic Oncology Task Force (OOTF) that under his guidance developed the first consensus staging system for ocular cancers which has been adopted by the Union International for Cancer Control (UICC). Similarly, Dr. Finger was invited to Chair and thus formed an OOTF for The American Brachytherapy Society (ABS) and American Association of Physicists in Medicine (AAPM) that provided international consensus guidelines for ophthalmic plaque brachytherapy for choroidal melanoma and retinoblastoma. In recognition of his expertise in ophthalmic radiation therapy and medical physics, Dr. Finger was the first ophthalmologist to ever serve on an AAPM Task Group-129 (TG-129) that produced both dosimetry and quality assurance standards for plaque brachytherapy. Recognizing the need to address the relatively unchecked worldwide mortality associated with the most common intraocular malignancy in children, Dr. Finger's has dedicated his time and support to develop fellowship programs directed at providing retinoblastoma specialists for underserved and unserved countries. Toward this aim, The Eye Cancer Foundation has funded fellowship education programs around the world. Confronted by the COVID-19 epidemic impeding this work, Dr. Finger and The Eye Cancer Foundation Board reached out to Dr. Yacoub Yousef to lead the International Retinoblastoma Comprehensive Course.

Dr. Yacoub A. Yousef

(IRBCC Director)

Dr. Yacoub A. Yousef has created the leading ocular oncology training service in the Middle East, supported (in part) by The Eye Cancer Foundation, Dr. Yousef heads the Retinoblastoma Service and the Ocular Oncology Unit at King Hussein Cancer Center (Amman, Jordan). He completed his basic medical education from The University of Jordan, and The Higher Specialization in Ophthalmology from The Jordan University Hospital. He completed his fellowship in Ocular Tumor, Orbital Disease and Ophthalmic Radiation Therapy at The New York Eye Cancer Center (NY, USA) followed by a fellowship in Retinoblastoma and Ocular Oncology at University of Toronto (Canada) under supervision of the world leaders in the field Dr.

Paul Finger and Dr. Brenda Gallie. Since, 2012, Dr. Yousef has been caring for eye cancer patients, teaching and publishing research as faculty at King Hussein Cancer Centre. Dr. Yousef has received the inaugural King Hussein Award for Cancer Research. In collaboration with The Eye Cancer Foundation and the ICO, he established the first ocular oncology fellowship program at the King Hussein Cancer Center and subsequently trained ophthalmologists interested in retinoblastoma from previously unserved and underserved countries all over the middle east. Dr. Yousef's research interests have included retinoblastoma, ocular melanoma, and ocular surface neoplasia. At the time of this writing, Dr. Yousef has published 65 peer-reviewed journal publications, has delivered more than 50 conference lectures, and multiple educational courses. Dr. Yousef appreciated the need for a consensus retinoblastoma course that could serve as a foundational element for subsequent clinical training, he has formed and directed the International Retinoblastoma Comprehensive Course

Dr. Swathi Kaliki

Dr. Saima Amin

Dr. Ankit S. Tomar

Dr. Ido Didi Fabian

Dr. Sonal P. Yadav

Dr. Sameh Soliman

Dr. Mona T. Mohammad

Dr. Hadeel Halalsheh

Participating Members

Objectives of the Course

At the completion of this course you will be able to:

An educational foundation to enhance clinical experience and care
Consensus guidelines provided by more than 50 retinoblastoma specialists
General principles of pathogenesis and genetics of retinoblastoma
General principles for diagnosis and management of retinoblastoma

View Syllabus

Introduction to The IRBCC
Clinical Diagnosis of Retinoblastoma
RB Genetics and counseling
Pathology for Retinoblastoma
Classification and Staging for Retinoblastoma
General Guidelines for management of Retinoblastoma
Systemic Chemotherapy for Retinoblastoma
Targeted Chemotherapy for Retinoblastoma
Local treatment for Retinoblastoma
Radiation treatment for Retinoblastoma
Surgical treatment for Retinoblastoma
Extraocular Retinoblastoma
Living with Retinoblastoma
Psychosocial impact of Retinoblastoma
Building RB service in developing countries
Real case scenarios and live videos

Target Audience

Ophthalmologists (General and Ophthalmic Oncology), Oncologists (General and Pediatric), Radiation Oncologists, Pathologists (General and Ophthalmic), Resident Ophthalmologists, Oncologists, Radiation Oncologists, Social Workers, and Psychologists

Disclaimer

The IRBCC Course is an educational material that will help to teach ophthalmologists the basics needed to understand pathogenesis and management for Retinoblastoma, however, it doesn’t replace adequate hands-on training for the management of this rare curable life-threatening disease.

DocMode acknowledges that no educational grants were received for the creation of this Internet Enduring activity.

Certification of Participation

Provided by: The Eye Cancer Foundation

Live Lecture FAQs

Which browser should I use?

The DocMode platform runs on the following browsers:
Firefox, Chrome, Safari and Internet Explorer
We generally encourage the use of, and fully support only, the latest version.

What kind of equipment do I need?

You only require a working computer/laptop/mobile and a stable internet connection and good audio (internal or external speakers, earphones or headset).

Does it cost anything to participate?

No. It is absolutely free of cost.

I can't attend the live lecture. Will the lecture be repeated? Is there any way to watch it later?

Yes, you can access the live lecture at a later date from your dashboard itself if you are enrolled for the same. Even if you haven’t enrolled for it, all live lectures hosted on DocMode.org are available for viewing under the Lectures section of the DocMode homepage.

International Retinoblastoma Comprehensive Course (IRBCC)